Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806321 · ClinicalTrials.gov registry record · NA
Project SOLVE: Trial of a Brief Digital Problem-solving Intervention
A NA study of Depression and Anxiety, sponsored by Harvard University.
- Completed
- Registry status
- NA
- Development phase
- 522
- Enrollment target
- 1
- Study location
NCT04806321: Completed NA study of Depression and Anxiety, sponsored by Harvard University.
NCT04806321 is a NA study of Depression and Anxiety that has completed, run by Harvard University. The registered enrollment target is 522 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04806321, a NA study of Depression and Anxiety, has completed, sponsored by Harvard University.
- COMPLETED
- Registry status
- NA
- Development phase
- 522 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this trial is to examine the effectiveness of a universal, self-guided, digital single-session intervention focusing on problem-solving skills in improving adolescent mental health and well-being, relative to an active control intervention focusing on study skills, within the context of school settings during the coronavirus disease pandemic.
Primary Outcome
Trajectories of self-reported symptoms of anxiety and depression from the 6-item (each item rated on a 0-4 scale, with higher ratings indicating more symptoms) Internalizing subscale of the Behavior and Feelings Survey. Total scores range from 0 to 24, with higher scores indicating more symptoms.
Conditions Studied
Interventions
- OTHER Project SOLVE
- OTHER Project SUCCESS
Study Locations (1)
Massachusetts
- Harvard University - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 522 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2022-05-15 |
| Phase | NA |
What the finished NCT04806321 record still lists
NCT04806321 is an interventional study that assigns participants to a tested intervention. The registered 522 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (34% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Project SOLVE is the first listed.
NCT04806321 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04806321 about?
NCT04806321 is a clinical study titled "Project SOLVE: Trial of a Brief Digital Problem-solving Intervention". The goal of this trial is to examine the effectiveness of a universal, self-guided, digital single-session intervention focusing on problem-solving skills in improving adolescent mental health and well-being, relative to an active control intervention focusing on study skills, within the context of ...
What is the current status of trial NCT04806321?
This trial is currently completed. It is a NA study. The enrollment target is 522 participants. The study started on 2021-03-15. Estimated completion is 2022-05-15.
What conditions does trial NCT04806321 study?
This clinical trial studies the following conditions: Depression, Anxiety, Stress.
What interventions are being tested in trial NCT04806321?
The interventions under investigation include: Project SOLVE (OTHER), Project SUCCESS (OTHER).
Who is sponsoring clinical trial NCT04806321?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04806321 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04806321's enrollment target sits among peer trials
522 76th of 679 higher than 604 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
- NCT06894212 · 522 participants · Phase 3
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- NCT03526835 · 523 participants · Phase 1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- NCT04580134 · 524 participants · Phase 4
CLOZAPINE Response in Biotype-1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy